Amylyx Pharmaceuticals, Inc. · NASDAQ:AMLX
Bedrosian Camille L sold 10,028 Amylyx Pharmaceuticals, Inc. shares (Form 4)
Traded Sep 10, 2026 · Filed Sep 14, 2026
On Sep 10, 2026, Bedrosian Camille L (Chief Medical Officer) sold 10,028 Amylyx Pharmaceuticals, Inc. shares at an average US$32.39 for US$325K, leaving 278,064 shares. Filed Sep 14, 2026 (Form 4).
- Sold
- 10,028 shares
- Price
- US$32.39 average (US$32.21 to US$33.09)
- Value
- US$325K
- Holding after
- 278,064 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 10, 2026 | Common Stock | Sale | 7,947 | US$32.21 | 280,145 | Direct |
| Sep 10, 2026 | Common Stock | Sale | 2,081 | US$33.09 | 278,064 | Direct |
Source
Related
- Amylyx Pharmaceuticals, Inc.
- Bedrosian Camille L
- Amylyx Pharmaceuticals, Inc. shareholders
- Form 4 · Bedrosian Camille L · Aug 20, 2026
- Form 4 · Milne George M Jr · Oct 7, 2026
- Form 4 · Frates James M · Sep 14, 2026
- Form 4 · Mazzariello Gina · Sep 14, 2026
- Form 4 · Cohen Joshua B · Sep 14, 2026
- Form 4 · Klee Justin B. · Sep 14, 2026